Windrose Medical Properties Trust Prices Equity Offering
April 12 2006 - 9:00AM
PR Newswire (US)
INDIANAPOLIS, April 12 /PRNewswire-FirstCall/ -- Windrose Medical
Properties Trust (NYSE:WRS), a self-managed specialty medical
properties REIT, announced today it has priced a public offering of
2,300,000 common shares at $14.80 per share. As part of the
offering, Windrose granted its underwriters a 30-day option to
purchase up to an additional 345,000 shares to cover
over-allotments. The net proceeds of the offering, after
underwriting discounts, commissions and estimated offering
expenses, and before giving effect to the over-allotment option, if
exercised, will be approximately $32.3 million. The proceeds will
be used to pay down Windrose's existing indebtedness and for
general corporate purposes, including possible future acquisitions
of specialty medical properties. Robert W. Baird & Co. was
sole-book runner and Raymond James & Associates, Inc. was
co-manager. The closing of the offering is expected to occur on
April 18, 2006 and is subject to customary closing conditions.
Copies of the prospectus supplement relating to the offering may be
obtained by contacting Robert W. Baird & Co. Incorporated, 777
East Wisconsin Avenue, Milwaukee, WI 53201. This press release
shall not constitute an offer to sell or the solicitation of an
offer to buy nor shall there be any sale or an offer to buy these
securities in any state in which such offer, solicitation or sale
would be unlawful prior to registration or qualification under the
securities laws of any such state. ABOUT WINDROSE Windrose is a
self-managed Real Estate Investment Trust (REIT) based in
Indianapolis, Indiana with offices in Nashville, Tennessee.
Windrose was formed to acquire, selectively develop and manage
specialty medical properties, such as medical office buildings,
ambulatory surgery centers, outpatient treatment and diagnostic
facilities and specialty hospitals and treatment centers. SAFE
HARBOR Some of the statements in this news release, including those
related to this offering and the use of proceeds, constitute
forward-looking statements. Such statements include, in particular,
statements about our beliefs, expectations, plans and strategies
that are not based on historical facts. You should not rely on our
forward-looking statements because the matters they describe are
subject to known and unknown risks, uncertainties, assumptions and
changes in circumstances, many of which are beyond our control,
which may cause our actual results to differ significantly from
those expressed in any forward-looking statement. The factors that
could cause actual results to differ materially from current
expectations include our ability to complete this offering, our
ability to deploy the net proceeds from the offering, changes in
economic and general business conditions and other factors
described from time to time in filings we make with the Securities
and Exchange Commission. The forward-looking statements contained
herein represent our judgment as of the date hereof, and we caution
readers not to place undue reliance on such statements. We do not
undertake to publicly update or revise any forward-looking
statement whether as a result of new information, future events or
otherwise. Contact: Windrose Medical Properties Trust Fred Farrar
President and COO 317-860-8213 Investors/Media: The Ruth Group
Stephanie Carrington/Jason Rando 646 536-7017/7025 DATASOURCE:
Windrose Medical Properties Trust CONTACT: Fred Farrar, President
and COO of Windrose Medical Properties Trust, +1-317-860-8213; or
Investors: Stephanie Carrington, +1-646-536-7017, , or Media: Jason
Rando, +1-646-536-7025, , both of The Ruth Group, for Windrose
Medical Properties Trust
Copyright
Windrose Medical (NYSE:WRS)
Historical Stock Chart
From Apr 2024 to May 2024
Windrose Medical (NYSE:WRS)
Historical Stock Chart
From May 2023 to May 2024